Selected stock price target news of the day - February 10th, 2025

By: Matthew Otto

Avantor Reports Q4 2024 Earnings Beat with Slight Revenue Shortfall

Avantor reported fourth-quarter 2024 financial results, achieving net sales of $1.69 billion, missing the consensus estimate of $1.71 billion. However, organic sales grew by 1% despite a 2% decline in total sales compared to the prior-year period.

Net income surged to $500.4 million from $98.5 million, yielding a net income margin of 29.7%. Adjusted EBITDA was $307.7 million with a margin of 18.2%. The diluted GAAP EPS stood at $0.73, while adjusted EPS came in at $0.27, surpassing analyst estimates by $0.01. Operating cash flow reached $173.3 million, with free cash flow totaling $222.1 million.

For the full year 2024, net sales totaled $6.78 billion, a 3% decrease compared to 2023, with a 2% organic sales decline. Net income rose to $711.5 million from $321.1 million, translating to a 10.5% net income margin. Adjusted EBITDA was $1.20 billion, with a 17.7% margin.

Full-year diluted GAAP EPS was $1.04, while adjusted EPS was $0.99. Operating cash flow for the year amounted to $840.8 million, and free cash flow was $768.3 million. Segment-wise, Laboratory Solutions reported Q4 net sales of $1.13 billion, down 5% year-over-year, while Bioscience Production achieved $560.8 million in sales, a 4% increase.

Analysts Adjust Price Targets Following Mixed Q4 2024 Results

Barclays analyst Luke Sergott maintained an Overweight rating but lowered the price target from $26 to $23.
Stifel analyst Daniel Arias kept a Buy rating, though reduced the price target from $28 to $26.
Wells Fargo analyst Brandon Couillard lowered the price target to $25 while.

Which Analyst has the best track record to show on AVTR?

Analyst Luke Sergott (BARCLAYS) currently has the highest performing score on AVTR with 13/23 (56.52%) price target fulfillment ratio. His price targets carry an average of $4.13 (18.88%) potential upside. Avantor stock price reaches these price targets on average within 142 days.

ConocoPhillips Faces Earnings Decline Amid Acquisition Costs but Projects Growth for 2025

ConocoPhillips concluded 2024 with acquisition of Marathon Oil and delivered a fourth-quarter earnings per share (EPS) of $1.90 and an adjusted EPS of $1.98, surpassing Wall Street estimates of $1.84. Quarterly earnings totaled $2.3 billion, down from $3.0 billion in the same period of 2023, due to lower commodity prices and acquisition-related expenses.

Production rose to 2.18 million barrels of oil equivalent per day (boepd), a 15% increase year-over-year. Full-year production averaged 1.987 million boepd, a 3% rise when adjusted for acquisitions. ConocoPhillips reported a reserve replacement ratio of 244% for 2024, with organic replacement at 123%. Cash provided by operations for the year was $20.1 billion, with $9.1 billion returned to shareholders, including $5.5 billion in share buybacks.

Looking forward, ConocoPhillips has set a capital expenditure target of $12.9 billion for 2025. Despite reducing spending on Lower 48 assets by 15%, ConocoPhillips expects 2025 production to range between 2.34 million and 2.38 million boepd. The planned return of capital to shareholders is projected at $10 billion, up from $9.1 billion in 2024.

Additionally, agreements have been signed to divest non-core Lower 48 assets with an output of 15,000 boepd for $600 million, expected to close in the first half of 2025. ConocoPhillips remains focused on achieving $1 billion in integration-related synergies from the Marathon Oil acquisition.

Analyst Updates Reflect Acquisition Costs and Earnings Decline

Barclays analyst Betty Jiang maintained an Overweight rating but reduced the price target from $137 to $135.
Raymond James analyst John Freeman downgraded from Strong Buy to Outperform and the price target from $157 to $124.
Wells Fargo analyst Roger Read cut the price target to $128.

Which Analyst has the best track record to show on COP?

Analyst Devin Mcdermott (MORGAN STANLEY) currently has the highest performing score on COP with 18/19 (94.74%) price target fulfillment ratio. His price targets carry an average of $27.08 (26.83%) potential upside. ConocoPhillips stock price reaches these price targets on average within 210 days.

Mohawk Fourth Quarter and Full-Year 2024 Performance Amid Challenging Market Conditions

Mohawk Industries announced fourth-quarter 2024 net earnings of $93 million, translating to earnings per share (EPS) of $1.48. On an adjusted basis, EPS was $1.95, beating the analyst estimate of $1.87 by $0.08. Adjusted net earnings for the quarter were $123 million.

Net sales stood at $2.64 billion, surpassing the consensus estimate of $2.54 billion and marking a 1.0% increase as reported but a 1.0% decrease on an adjusted basis compared to the same period in 2023. In comparison, the fourth quarter of 2023 recorded net sales of $2.6 billion, net earnings of $140 million, and an EPS of $2.18.

Full-year 2024 net earnings totaled $518 million, with an EPS of $8.14, while adjusted net earnings reached $617 million, resulting in an adjusted EPS of $9.70. Annual net sales amounted to $10.8 billion, reflecting a 2.7% decrease as reported and a 3.3% decline on an adjusted basis year-over-year.

Mohawk Industries implemented restructuring actions and productivity improvements, contributing to a 6% increase in full-year adjusted EPS. The Global Ceramic Segment’s fourth-quarter net sales increased by 1.5%, while operating margins were reduced due to unfavorable pricing and mix. The Flooring North America Segment saw a 2.8% sales increase, though margins were impacted by higher input costs. The Flooring Rest of the World Segment experienced a 2.1% sales decrease.

Looking ahead, Mohawk expects first-quarter 2025 adjusted EPS to range between $1.34 and $1.44, factoring in a $25 million to $30 million impact from recent system implementation issues.

Analyst Highlight Price Target Adjustments Following Q4 Results

Barclays analyst Matthew Bouley maintained an Equal-Weight rating while lowering the price target from $130 to $125.
Baird analyst Timothy Wojs reiterated an Outperform rating yet adjusted the price target downward from $160 to $152.
BofA Securities analyst Rafe Jadrosich kept a Buy rating but reduced the price target from $152 to $150.
JPMorgan analyst Michael Rehaut lowered the price target to $156.
Raymond James analyst Sam Darkatsh lowered the price target from $185 to $165.
Truist Securities analyst Keith Hughes cut the price target to $148.

Which Analyst has the best track record to show on MHK?

Analyst Philip Ng (JEFFERIES) currently has the highest performing score on MHK with 18/20 (90%) price target fulfillment ratio. His price targets carry an average of $1 (0.63%) potential upside. Mohawk Industries stock price reaches these price targets on average within 176 days.